361 Capital’s Insmed INSM Stock Holding History

361 Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-72,768	Closed	-$1.74M	–	334
2019 Q4	$1.74M	Sell	72,768 -80,329	-52%	-$1.63M	0.48%	34
2019 Q3	$2.7M	Buy	+153,097	New	+$2.96M	0.5%	57

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

361 Capital's INSM Position: Q1 2020 in Review

361 Capital sold out of Insmed (INSM) in Q1 2020, closing a stake of 72,768 shares — an estimated $1.74M sold.

361 Capital first reported a position in INSM in Q3 2019 and held it in 2 quarters. The position peaked at $2.7M in Q3 2019. 165 funds tracked by Wall St. Rank hold INSM as of Q1 2020.

361 Capital reported no remaining Insmed position as of Q1 2020 after selling out during the quarter.
361 Capital sold 72,768 Insmed shares in Q1 2020, an estimated $1.74M.
361 Capital first reported a position in Insmed in Q3 2019 and held it in 2 quarters.
361 Capital's Insmed position peaked at $2.7M in Q3 2019.
165 funds tracked by Wall St. Rank held Insmed as of Q1 2020.

Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.